Table:
begin	end	state
1	46	non-cytoplasmic
47	70	transmembrane
71	81	cytoplasmic
82	105	transmembrane
106	116	non-cytoplasmic
117	148	transmembrane
149	158	cytoplasmic
159	180	transmembrane
181	198	non-cytoplasmic
199	223	transmembrane
224	253	cytoplasmic
254	275	transmembrane
276	282	non-cytoplasmic
283	301	transmembrane
302	307	cytoplasmic
308	327	transmembrane
328	332	non-cytoplasmic
333	353	transmembrane
354	359	cytoplasmic

Input:
>SMa0217 FitnessBrowser__Smeli:SMa0217
MGARRRARPVPRSPTIECQTVTPVLAESAAPRSRTQRQSILKQIMGMPAGAIFLVFMTLQ
IVCIAGALLYPDEFRYLSPQNLTILMKAIPVLGCLALGAGVLMIAGEFDLSIGSVYTFTA
VLMASLVNAGLSAFIAAPIAILTGLLIGSLNGHITLRFGLPSFIVTLGGLLFWRGAVLLY
NGAVQVRFDPEPVFTSLFSGTLFGVNAAFIWIVLFVTGFHLLLHRHRFGNHVFATGGNRG
AAEAIGINTSRVKLIAFAIAGGMAAVAGILATARVGSVQPGQGAGLELQAIAACVIGGLS
LRGGRGSIIGIFLGVLLIHTITDVLLLLRAPGFYLDMFIATLIVLAAIFNHLIERRGLA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server